PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1954808
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1954808
Mycoplasma Testing Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
Growth Factors of mycoplasma testing Market
The global mycoplasma testing market was valued at USD 972.3 million in 2025. The market is projected to grow to USD 1,021.10 million in 2026 and further reach USD 1,551.70 million by 2034, registering a CAGR of 5.40% during the forecast period (2026-2034).
North America dominated the market with a 49.20% share in 2025, supported by strong research infrastructure, rising regulatory initiatives, and high R&D expenditure.
Mycoplasma are the smallest free-living organisms and are among the most common contaminants in cell cultures and biopharmaceutical production. Due to their lack of a rigid cell wall, they are resistant to many antibiotics and can pass through standard filtration systems. This makes routine mycoplasma testing essential in research laboratories, vaccine production, and biologics manufacturing to prevent contamination and financial losses.
COVID-19 Impact
The COVID-19 pandemic positively impacted the market due to increased storage and testing of cell cultures for vaccine and drug development. The surge in vaccine R&D significantly increased demand for testing kits and reagents in 2020. Although demand normalized in 2021, continued R&D activities for chronic diseases and infectious conditions are expected to support steady market growth through 2034.
Market Trends
Increasing Strategic Partnerships
Rising demand for advanced testing technologies has led to increased collaborations among diagnostic companies. Market players are focusing on mergers, acquisitions, and partnerships to combine expertise and enhance product portfolios. Technological advancements aimed at reducing turnaround time and improving sensitivity are gaining traction among pharmaceutical and biotechnology companies.
Technological Advancements in PCR-Based Testing
PCR-based testing methods are becoming more popular due to their high sensitivity, specificity, and faster results. Adoption of nucleic acid amplification techniques (NAT) and regulatory guideline updates are further accelerating the use of advanced testing solutions.
Market Growth Drivers
The increasing R&D expenditure among biopharmaceutical and biotechnology companies is a major driver. Growing investments in vaccine development, cell therapies, and biologics require strict contamination control measures, boosting demand for testing kits.
Rising healthcare expenditure globally and growing awareness regarding cell culture contamination are further contributing to market growth. Updated regulatory standards and quality control guidelines are encouraging routine testing in laboratories and research facilities.
Restraining Factors
High costs associated with advanced testing kits and instruments may limit adoption in emerging markets. PCR-based kits and detection systems require specialized equipment and trained professionals, increasing overall operational costs. Additionally, the shortage of skilled laboratory personnel globally may hinder market expansion in certain regions.
Segmentation Analysis
By Product
The market is segmented into reagents & kits and instruments.
- The reagents & kits segment dominated the market with a 57.85% share in 2026, driven by their frequent usage in routine laboratory testing and rising product launches.
- The instruments segment is expected to grow steadily due to increasing penetration in emerging markets and technological advancements.
By Testing Method
The market is categorized into PCR-based, culture-based, and others.
- The PCR-based segment is projected to lead with a 56.92% share in 2026, owing to high sensitivity, efficiency, and shorter turnaround time.
- The culture-based segment is expected to grow at a slower rate due to longer processing time and lower sensitivity, although its lower cost supports adoption in developing regions.
By Application
Applications include cell culture, vaccine testing, virus testing, and others.
- The cell culture segment will account for 37.36% share in 2026, supported by rising contamination concerns and increasing research activities.
- The virus testing segment is anticipated to register the highest CAGR through 2034 due to increasing outbreak monitoring.
- Vaccine testing continues to benefit from growing immunization programs and R&D investments.
By End-user
The market is segmented into biopharmaceutical & biotechnology companies, cell banks, CROs & CMOs, and others.
- The biopharmaceutical & biotechnology companies segment is projected to lead with a 32.99% share, driven by expanding R&D pipelines.
- The cell banks segment is expected to register the highest CAGR due to growing storage of stem cells and other biological samples.
Regional Insights
North America
North America remains the dominant region. The market in the region reached USD 503.2 million in 2026, with the U.S. market estimated at USD 459.6 million in 2026. Strong government funding and vaccine development initiatives continue to drive demand.
Europe
Europe is expected to grow at a moderate rate. The UK market is projected to reach USD 49.3 million by 2026, while Germany is estimated at USD 37.7 million in 2026, supported by rising R&D investments.
Asia Pacific
Asia Pacific is projected to register the highest CAGR through 2034. Japan is estimated to reach USD 52.4 million by 2026, China USD 42.3 million, and India USD 37.8 million, driven by increasing collaborations and expanding biopharmaceutical sectors.
Competitive Landscape
The market is fragmented, with key players including Merck KGaA, Thermo Fisher Scientific Inc., Lonza, F. Hoffmann-La Roche Ltd., Sartorius AG, bioMerieux SA, and Asahi Kasei Corporation.
Companies are focusing on technological innovation, product launches, partnerships, and facility expansions to strengthen their global presence. Strategic initiatives and R&D investments are expected to intensify competition through 2034.
Conclusion
The global mycoplasma testing market is projected to grow from USD 972.3 million in 2025 to USD 1,551.70 million by 2034, driven by rising R&D activities, increasing contamination concerns, and technological advancements in PCR-based testing. While high costs and skilled workforce shortages may restrain growth in emerging markets, expanding vaccine production, biologics development, and regulatory compliance requirements will sustain long-term market expansion. North America will continue to dominate, while Asia Pacific is expected to witness the fastest growth through 2034.
Segmentation By Testing Method
- PCR-based
- Culture-based
- Others
By Product
- Instruments
- Reagents & Kits
By Application
- Cell Culture
- Vaccine Testing
- Virus Testing
- Others
By End-user
- Biopharmaceutical & Biotechnology Companies
- Cell banks
- Contract Research Organizations & Contract Manufacturing Organizations
- Others
By Region
- North America (By Testing Method, Product, Application, End-user, and By Country)
- U.S. (By Testing Method)
- Canada (By Testing Method)
- Europe (By Testing Method, Product, Application, End-user, and Country/Sub-region)
- U.K. (By Testing Method)
- Germany (By Testing Method)
- France (By Testing Method)
- Italy (By Testing Method)
- Spain (By Testing Method)
- Rest of Europe (By Testing Method)
- Asia Pacific (By Testing Method, Product, Application, End-user, and Country/Sub-region)
- China (By Testing Method)
- Japan (By Testing Method)
- India (By Testing Method)
- Australia (By Testing Method)
- Southeast Asia (By Testing Method)
- Rest of Asia Pacific (By Testing Method)
- Rest of the World (By Testing Method, Product, Application, and End-user)
Table of Content
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
4. Key Insights
- 4.1. Overview of R&D Expenditure, Key Regions/Key Countries, 2025
- 4.2. Technological Advancements in Mycoplasma Testing
- 4.3. Key Industry Developments - Mergers, Acquisitions & Partnership
- 4.4. New Product Launches
- 4.5. Impact of COVID-19 on the Market
5. Global Mycoplasma Testing Market Analysis, Insights and Forecast, 2021-2034
- 5.1. Market Analysis, Insights and Forecast - By Testing Method
- 5.1.1. PCR-based
- 5.1.2. Culture-based
- 5.1.3. Others
- 5.2. Market Analysis, Insights and Forecast - By Product
- 5.2.1. Instruments
- 5.2.2. Reagents & Kits
- 5.3. Market Analysis, Insights and Forecast - By Application
- 5.3.1. Cell Culture
- 5.3.2. Vaccine Testing
- 5.3.3. Virus Testing
- 5.3.4. Others
- 5.4. Market Analysis, Insights and Forecast - By End User
- 5.4.1. Biopharmaceutical & Biotechnology Companies
- 5.4.2. Cell banks
- 5.4.3. Contract Research Organizations & Contract Manufacturing Organizations
- 5.4.4. Others
- 5.5. Market Analysis, Insights and Forecast - By Region
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Rest of the World
6. North America Mycoplasma Testing Market Analysis, Insights and Forecast, 2021-2034
- 6.1. Market Analysis, Insights and Forecast - By Testing Method
- 6.1.1. PCR-based
- 6.1.2. Culture-based
- 6.1.3. Others
- 6.2. Market Analysis, Insights and Forecast - By Product
- 6.2.1. Instruments
- 6.2.2. Reagents & Kits
- 6.3. Market Analysis, Insights and Forecast - By Application
- 6.3.1. Cell Culture
- 6.3.2. Vaccine Testing
- 6.3.3. Virus Testing
- 6.3.4. Others
- 6.4. Market Analysis, Insights and Forecast - By End User
- 6.4.1. Biopharmaceutical & Biotechnology Companies
- 6.4.2. Cell banks
- 6.4.3. Contract Research Organizations & Contract Manufacturing Organizations
- 6.4.4. Others
- 6.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 6.5.1. U.S.
- 6.5.1.1. By Testing Method
- 6.5.2. Canada
- 6.5.2.1. By Testing Method
- 6.5.1. U.S.
7. Europe Mycoplasma Testing Market Analysis, Insights and Forecast, 2021-2034
- 7.1. Market Analysis, Insights and Forecast - By Testing Method
- 7.1.1. PCR-based
- 7.1.2. Culture-based
- 7.1.3. Others
- 7.2. Market Analysis, Insights and Forecast - By Product
- 7.2.1. Instruments
- 7.2.2. Reagents & Kits
- 7.3. Market Analysis, Insights and Forecast - By Application
- 7.3.1. Cell Culture
- 7.3.2. Vaccine Testing
- 7.3.3. Virus Testing
- 7.3.4. Others
- 7.4. Market Analysis, Insights and Forecast - By End User
- 7.4.1. Biopharmaceutical & Biotechnology Companies
- 7.4.2. Cell banks
- 7.4.3. Contract Research Organizations & Contract Manufacturing Organizations
- 7.4.4. Others
- 7.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 7.5.1. U.K
- 7.5.1.1. By Testing Method
- 7.5.2. Germany
- 7.5.2.1. By Testing Method
- 7.5.3. France
- 7.5.3.1. By Testing Method
- 7.5.4. Spain
- 7.5.4.1. By Testing Method
- 7.5.5. Italy
- 7.5.5.1. By Testing Method
- 7.5.6. Rest of Europe
- 7.5.6.1. By Testing Method
- 7.5.1. U.K
8. Asia Pacific Mycoplasma Testing Market Analysis, Insights and Forecast, 2021-2034
- 8.1. Market Analysis, Insights and Forecast - By Testing Method
- 8.1.1. PCR-based
- 8.1.2. Culture-based
- 8.1.3. Others
- 8.2. Market Analysis, Insights and Forecast - By Product
- 8.2.1. Instruments
- 8.2.2. Reagents & Kits
- 8.3. Market Analysis, Insights and Forecast - By Application
- 8.3.1. Cell Culture
- 8.3.2. Vaccine Testing
- 8.3.3. Virus Testing
- 8.3.4. Others
- 8.4. Market Analysis, Insights and Forecast - By End User
- 8.4.1. Biopharmaceutical & Biotechnology Companies
- 8.4.2. Cell banks
- 8.4.3. Contract Research Organizations & Contract Manufacturing Organizations
- 8.4.4. Others
- 8.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 8.5.1. Japan
- 8.5.1.1. By Testing Method
- 8.5.2. China
- 8.5.2.1. By Testing Method
- 8.5.3. India
- 8.5.3.1. By Testing Method
- 8.5.4. Australia
- 8.5.4.1. By Testing Method
- 8.5.5. Southeast Asia
- 8.5.5.1. By Testing Method
- 8.5.6. Rest of Asia Pacific
- 8.5.6.1. By Testing Method
- 8.5.1. Japan
9. Rest of the World Mycoplasma Testing Market Analysis, Insights and Forecast, 2021-2034
- 9.1. Market Analysis, Insights and Forecast - By Testing Method
- 9.1.1. PCR-based
- 9.1.2. Culture-based
- 9.1.3. Others
- 9.2. Market Analysis, Insights and Forecast - By Product
- 9.2.1. Instruments
- 9.2.2. Reagents & Kits
- 9.3. Market Analysis, Insights and Forecast - By Application
- 9.3.1. Cell Culture
- 9.3.2. Vaccine Testing
- 9.3.3. Virus Testing
- 9.3.4. Others
- 9.4. Market Analysis, Insights and Forecast - By End User
- 9.4.1. Biopharmaceutical & Biotechnology Companies
- 9.4.2. Cell banks
- 9.4.3. Contract Research Organizations & Contract Manufacturing Organizations
- 9.4.4. Others
10. Competitive Analysis
- 10.1. Global Market Share Analysis (2025)
- 10.2. Company Profiles
- 10.2.1. Merck KGaA
- 10.2.1.1. Overview
- 10.2.1.2. Product
- 10.2.1.3. SWOT Analysis
- 10.2.1.4. Recent Developments
- 10.2.1.5. Strategies
- 10.2.1.6. financials (Based on Availability)
- 10.2.2. Thermo Fisher Scientific Inc.
- 10.2.2.1. Overview
- 10.2.2.2. Product
- 10.2.2.3. SWOT Analysis
- 10.2.2.4. Recent Developments
- 10.2.2.5. Strategies
- 10.2.2.6. financials (Based on Availability)
- 10.2.3. F. Hoffmann-La Roche Ltd.
- 10.2.3.1. Overview
- 10.2.3.2. Product
- 10.2.3.3. SWOT Analysis
- 10.2.3.4. Recent Developments
- 10.2.3.5. Strategies
- 10.2.3.6. financials (Based on Availability)
- 10.2.4. Sartorius AG
- 10.2.4.1. Overview
- 10.2.4.2. Product
- 10.2.4.3. SWOT Analysis
- 10.2.4.4. Recent Developments
- 10.2.4.5. Strategies
- 10.2.4.6. financials (Based on Availability)
- 10.2.5. Asahi Kasei Corporation
- 10.2.5.1. Overview
- 10.2.5.2. Product
- 10.2.5.3. SWOT Analysis
- 10.2.5.4. Recent Developments
- 10.2.5.5. Strategies
- 10.2.5.6. financials (Based on Availability)
- 10.2.6. Biomeriux SA
- 10.2.6.1. Overview
- 10.2.6.2. Product
- 10.2.6.3. SWOT Analysis
- 10.2.6.4. Recent Developments
- 10.2.6.5. Strategies
- 10.2.6.6. financials (Based on Availability)
- 10.2.7. Charles River Laboratories
- 10.2.7.1. Overview
- 10.2.7.2. Product
- 10.2.7.3. SWOT Analysis
- 10.2.7.4. Recent Developments
- 10.2.7.5. Strategies
- 10.2.7.6. financials (Based on Availability)
- 10.2.8. ATCC
- 10.2.8.1. Overview
- 10.2.8.2. Product
- 10.2.8.3. SWOT Analysis
- 10.2.8.4. Recent Developments
- 10.2.8.5. Strategies
- 10.2.8.6. financials (Based on Availability)
- 10.2.9. Other Prominent Players
- 10.2.1. Merck KGaA
List of Tables
- Table 1: Global Mycoplasma Testing Market Revenue (USD million) Forecast, by Testing Method, 2021-2034
- Table 2: Global Mycoplasma Testing Market Revenue (USD million) Forecast, by Product, 2021-2034
- Table 3: Global Mycoplasma Testing Market Revenue (USD million) Forecast, by Application, 2021-2034
- Table 4: Global Mycoplasma Testing Market Revenue (USD million) Forecast, by End-user, 2021-2034
- Table 5: Global Mycoplasma Testing Market Revenue (USD million) Forecast, by Region, 2021-2034
- Table 6: North America Mycoplasma Testing Market Revenue (USD million) Forecast, by Testing Method, 2021-2034
- Table 7: North America Mycoplasma Testing Market Revenue (USD million) Forecast, by Product, 2021-2034
- Table 8: North America Mycoplasma Testing Market Revenue (USD million) Forecast, by Application, 2021-2034
- Table 9: North America Mycoplasma Testing Market Revenue (USD million) Forecast, by End-user, 2021-2034
- Table 10: North America Mycoplasma Testing Market Revenue (USD million) Forecast, By Country, 2021-2034
- Table 11: U.S. Mycoplasma Testing Market Revenue (USD million) Forecast, by Testing Method, 2021-2034
- Table 12: Canada Mycoplasma Testing Market Revenue (USD million) Forecast, by Testing Method, 2021-2034
- Table 13: Europe Mycoplasma Testing Market Revenue (USD million) Forecast, by Testing Method, 2021-2034
- Table 14: Europe Mycoplasma Testing Market Revenue (USD million) Forecast, by Product, 2021-2034
- Table 15: Europe Mycoplasma Testing Market Revenue (USD million) Forecast, by Application, 2021-2034
- Table 16: Europe Mycoplasma Testing Market Revenue (USD million) Forecast, by End-user, 2021-2034
- Table 17: Europe Mycoplasma Testing Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
- Table 18: U.K. Mycoplasma Testing Market Revenue (USD million) Forecast, by Testing Method, 2021-2034
- Table 19: Germany Mycoplasma Testing Market Revenue (USD million) Forecast, by Testing Method, 2021-2034
- Table 20: France Mycoplasma Testing Market Revenue (USD million) Forecast, by Testing Method, 2021-2034
- Table 21: Italy Mycoplasma Testing Market Revenue (USD million) Forecast, by Testing Method, 2021-2034
- Table 22: Spain Mycoplasma Testing Market Revenue (USD million) Forecast, by Testing Method, 2021-2034
- Table 23: Rest of Europe Mycoplasma Testing Market Revenue (USD million) Forecast, by Testing Method, 2021-2034
- Table 24: Asia Pacific Mycoplasma Testing Market Revenue (USD million) Forecast, by Testing Method, 2021-2034
- Table 25: Asia Pacific Mycoplasma Testing Market Revenue (USD million) Forecast, by Product, 2021-2034
- Table 26: Asia Pacific Mycoplasma Testing Market Revenue (USD million) Forecast, by Application, 2021-2034
- Table 27: Asia Pacific Mycoplasma Testing Market Revenue (USD million) Forecast, by End-user, 2021-2034
- Table 28: Asia Pacific Mycoplasma Testing Market Revenue (USD million) Forecast, By Country/ Sub-region, 2021-2034
- Table 29: China Mycoplasma Testing Market Revenue (USD million) Forecast, by Testing Method, 2021-2034
- Table 30: Japan Mycoplasma Testing Market Revenue (USD million) Forecast, by Testing Method, 2021-2034
- Table 31: India Mycoplasma Testing Market Revenue (USD million) Forecast, by Testing Method, 2021-2034
- Table 32: Australia Mycoplasma Testing Market Revenue (USD million) Forecast, by Testing Method, 2021-2034
- Table 33: Southeast Asia Mycoplasma Testing Market Revenue (USD million) Forecast, by Testing Method, 2021-2034
- Table 34: Rest of Asia Pacific Mycoplasma Testing Market Revenue (USD million) Forecast, by Testing Method, 2021-2034
- Table 35: Rest of the World Mycoplasma Testing Market Revenue (USD million) Forecast, by Testing Method, 2021-2034
- Table 36: Rest of the World Mycoplasma Testing Market Revenue (USD million) Forecast, by Product, 2021-2034
- Table 37: Rest of the World Mycoplasma Testing Market Revenue (USD million) Forecast, by Application, 2021-2034
- Table 38: Rest of the World Mycoplasma Testing Market Revenue (USD million) Forecast, by End-user, 2021-2034
List of Figures
- Figure 1: Global Mycoplasma Testing Market Revenue Breakdown (USD million, %) by Region, 2025 & 2034
- Figure 2: Global Mycoplasma Testing Market Value Share (%), by Testing Method, 2025 & 2034
- Figure 3: Global Mycoplasma Testing Market Value Share (%), by Product, 2025 & 2034
- Figure 4: Global Mycoplasma Testing Market Value Share (%), by Application, 2025 & 2034
- Figure 5: Global Mycoplasma Testing Market Value Share (%), by End-user, 2025 & 2034
- Figure 6: Global Mycoplasma Testing Market Value (USD million), by Region, 2025 & 2034
- Figure 7: North America Mycoplasma Testing Market Value (USD million), by Testing Method, 2025 & 2034
- Figure 8: North America Mycoplasma Testing Market Value Share (%), by Testing Method, 2025
- Figure 9: North America Mycoplasma Testing Market Value (USD million), by Product, 2025 & 2034
- Figure 10: North America Mycoplasma Testing Market Value Share (%), by Product, 2025
- Figure 11: North America Mycoplasma Testing Market Value (USD million), by Application, 2025 & 2034
- Figure 12: North America Mycoplasma Testing Market Value Share (%), by Application, 2025
- Figure 13: North America Mycoplasma Testing Market Value (USD million), by End-user, 2025 & 2034
- Figure 14: North America Mycoplasma Testing Market Value Share (%), by End-user, 2025
- Figure 15: North America Mycoplasma Testing Market Value (USD million), By Country, 2025 & 2034
- Figure 16: North America Mycoplasma Testing Market Value Share (%), By Country, 2025
- Figure 17: Europe Mycoplasma Testing Market Value (USD million), by Testing Method, 2025 & 2034
- Figure 18: Europe Mycoplasma Testing Market Value Share (%), by Testing Method, 2025
- Figure 19: Europe Mycoplasma Testing Market Value (USD million), by Product, 2025 & 2034
- Figure 20: Europe Mycoplasma Testing Market Value Share (%), by Product, 2025
- Figure 21: Europe Mycoplasma Testing Market Value (USD million), by Application, 2025 & 2034
- Figure 22: Europe Mycoplasma Testing Market Value Share (%), by Application, 2025
- Figure 23: Europe Mycoplasma Testing Market Value (USD million), by End-user, 2025 & 2034
- Figure 24: Europe Mycoplasma Testing Market Value Share (%), by End-user, 2025
- Figure 25: Europe Mycoplasma Testing Market Value (USD million), By Country/ Sub-region, 2025 & 2034
- Figure 26: Europe Mycoplasma Testing Market Value Share (%), By Country/ Sub-region, 2025
- Figure 27: Asia Pacific Mycoplasma Testing Market Value (USD million), by Testing Method, 2025 & 2034
- Figure 28: Asia Pacific Mycoplasma Testing Market Value Share (%), by Testing Method, 2025
- Figure 29: Asia Pacific Mycoplasma Testing Market Value (USD million), by Product, 2025 & 2034
- Figure 30: Asia Pacific Mycoplasma Testing Market Value Share (%), by Product, 2025
- Figure 31: Asia Pacific Mycoplasma Testing Market Value (USD million), by Application, 2025 & 2034
- Figure 32: Asia Pacific Mycoplasma Testing Market Value Share (%), by Application, 2025
- Figure 33: Asia Pacific Mycoplasma Testing Market Value (USD million), by End-user, 2025 & 2034
- Figure 34: Asia Pacific Mycoplasma Testing Market Value Share (%), by End-user, 2025
- Figure 35: Asia Pacific Mycoplasma Testing Market Value (USD million), By Country/ Sub-region, 2025 & 2034
- Figure 36: Asia Pacific Mycoplasma Testing Market Value Share (%), By Country/ Sub-region, 2025
- Figure 37: Rest of the World Mycoplasma Testing Market Value (USD million), by Testing Method, 2025 & 2034
- Figure 38: Rest of the World Mycoplasma Testing Market Value Share (%), by Testing Method, 2025
- Figure 39: Rest of the World Mycoplasma Testing Market Value (USD million), by Product, 2025 & 2034
- Figure 40: Rest of the World Mycoplasma Testing Market Value Share (%), by Product, 2025
- Figure 41: Rest of the World Mycoplasma Testing Market Value (USD million), by Application, 2025 & 2034
- Figure 42: Rest of the World Mycoplasma Testing Market Value Share (%), by Application, 2025
- Figure 43: Rest of the World Mycoplasma Testing Market Value (USD million), by End-user, 2025 & 2034
- Figure 44: Rest of the World Mycoplasma Testing Market Value Share (%), by End-user, 2025
- Figure 45: Global Mycoplasma Testing Market Share (%), By Company, 2025
